9 METERS BIOPHARMA INC's ticker is NMTR and the CUSIP is 654405109. A total of 104 filers reported holding 9 METERS BIOPHARMA INC in Q4 2021. The put-call ratio across all filers is 0.73 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $6,000 | -53.8% | 22,000 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $13,000 | -53.6% | 22,000 | -24.4% | 0.00% | -50.0% |
| Q4 2021 | $28,000 | -47.2% | 29,100 | -28.8% | 0.00% | -60.0% |
| Q3 2021 | $53,000 | -53.5% | 40,850 | -60.9% | 0.01% | -16.7% |
| Q2 2021 | $114,000 | +86.9% | 104,400 | +99.0% | 0.01% | 0.0% |
| Q1 2021 | $61,000 | – | 52,450 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 25,716,755 | $20,489,000 | 0.26% |
| Atlas Private Wealth Advisors | 20,000 | $16,000 | 0.01% |
| Lindbrook Capital, LLC | 40,000 | $33,000 | 0.01% |
| Prospera Financial Services Inc | 15,000 | $12,000 | 0.01% |
| Virtu Financial LLC | 37,982 | $31,000 | 0.01% |
| Cypress Wealth Services, LLC | 25,500 | $21,000 | 0.01% |
| ExodusPoint Capital Management, LP | 180,096 | $147,000 | 0.00% |
| Qube Research & Technologies Ltd | 232,248 | $189,000 | 0.00% |
| Ashfield Capital Partners, LLC | 33,353 | $27,000 | 0.00% |
| Heritage Wealth Advisors | 20,000 | $16,300,000 | 0.00% |